Laurence Reid bought $23K of MGX stock

Laurence Reid, Dir of Metagenomi Therapeutics, Inc. (MGX), bought 20,000 shares of MGX stock worth $23K, per an SEC Form 4 filed Sep 11, 2026.

It was an open-market purchase.

The trade happened on Sep 9, 2026, 2 days before it was made public.

MGX has moved -37.9% since the trade date, from $1.15 to $0.71 (Nov 12, 2026 close).